Dr. Seema Singh joined MCI in 2009 as Instructor of Oncologic Sciences. She quickly established a robust, independent laboratory program and was promoted to Assistant Professor in 2012 and then to Associate Professor in 2016. Her primary areas of interest include the role of inflammatory signaling in cancer progression, angiogenesis and metastasis, cancer stem cells and cancer health disparities. After obtaining a Ph.D. in India in 2001, she received postdoctoral training at University of Nebraska Medical Center in the area of tumor microenvironment, and breast and melanoma pathobiology. She is currently focused on the identification of novel targets in melanoma, and investigating the role of inflammatory and DNA damage pathways in the etiology and progression of non-melanoma skin cancer. Her team has discovered a novel role of silver nanoparticles (AgNPs) in the protection of keratinocytes from UV radiation-induced DNA damage and apoptosis. She is also exploring the role of differential tumor microenvironment in breast cancer racial disparity. Her research programs have been funded through NIH/NCI, and she has also served on peer review committees to evaluate grant applications.

Inflammation and Cancer, Tumor Microenvironment, Tumor Progression and Metastasis, Molecular bases of cancer health disparities, Nanobiotechnology